San Francisco, California, United States Related Funds
| Fund Name | Location |
| Bailihong Chuangtou | China, Guangdong, Shenzhen |
| Basil Partners | Central Region, Singapore, Singapore |
| Calpoly Ventures | - |
| Cleveland Clinic Innovations | Cleveland, Ohio, United States |
| CN-Healthcare | Beijing, China, Haidian |
| Cox Automotive | Atlanta, Georgia, United States |
| Daxin Chuangtou | China, Guangdong Province, Panyu District |
| ETFS Capital | England, London, United Kingdom |
| Gaydoul Group | Pfaffikon, Switzerland, Zurich |
| Horatio Ventures NYC | - |
| IdeaLab Capital Partners | California, Pasadena, United States |
| Madhu Kela Family Office | - |
| MAF Mauritius | - |
| Montrose Capital Partners | New York, New York, United States |
| OpenDoor Venture Capital | New York, New York, United States |
| Parker Institute for Cancer Immunotherapy | California, San Francisco, United States |
| Synergy Marketing | Japan, Osaka, Osaka Prefecture |
| ThedaCare | Appleton, United States, Wisconsin |
| Venture Farmers | - |
| Xoogler | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Procyon.ai | 15 Apr 2022 | - | |||
Docyt | $11M | 06 Apr 2022 | Sunnyvale, California, United States | ||
Reposify | $8M | 14 Dec 2021 | San Francisco, California, United States | ||
Peritus.ai | $1M | 14 Sep 2021 | Palo Alto, California, United States | ||
Arnica | $5M | 02 Aug 2021 | Alpharetta, Georgia, United States | ||
Dendron | $2M | 09 Apr 2021 | Seattle, Washington, United States | ||
Blotout | $3M | 22 Mar 2021 | Fremont, California, United States | ||
Essenvia | $500K | 28 Feb 2021 | Los Angeles, California, United States | ||
Docyt | $1M | 25 Feb 2021 | Sunnyvale, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
